This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

7 Most Reliable Growth Stocks in the Market

Were it not for the cool-down in natural gas prices over the past 18 months, Cabot's sales and profits would have been exploding by now. Instead, sales are likely to rise around 20% this year (to $1.18 billion). Yet analysts think that natural gas prices will rebound moderately in 2013, setting the stage for sales growth of around 40%.

Analysts at Brean Murray suggest you value this stock based on the value of its real estate. They think the net asset value stands at around $60, well above the current $40 stock price.

>>7 Undervalued Oil & Gas Stocks Ripe for Gains

Salix Pharmaceuticals

Gastro-intestinal distress is no laughing matter, as anyone with its symptoms will tell you. From Crohn's disease to irritable bowel syndrome to plain old cramping, GI distress can force one to drop plans on a moment's notice, and lead them to stay close to home.

Fortunately, Salix Pharmaceuticals (SLXP) has been making tremendous progress in this area. Salix's Xifaxan has been prescribed by an increasing number of doctor's for symptoms of diarrhea, enabling many people to resume more normal lives. The drug has powered Salix's income statement, from under $200 million in 2008 to $540 million in 2011.

>>5 Biotech Stocks Poised for Breakouts

And that revenue base could swell a lot higher if Salix's Solesta drug is as successful as analysts anticipate. The injectable drug has had great success in clinical trials, helping bulk up loose stool. The drug is a lot more powerful than traditional anti-diarrhea drugs you can buy at a pharmacy, though a lot less invasive than the major bowel surgery that some people require.

Analysts at Merrill Lynch anticipate a launch in 2013 for Solesta, and see sales for this drug rising to $250 million by 2016. That should enable Salix Pharma to maintain its robust pace of 20+% annual growth.

To see these stocks in action, visit the 7 Stocks With Strong and Steady Sales Growth portfolio.


Follow Stockpickr on Twitter and become a fan on Facebook.
Stockpickr is a wholly owned subsidiary of

At the time of publication, author had no positions in stocks mentioned.
3 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
SLXP $172.81 0.09%
AMZN $659.59 0.00%
COG $23.40 0.00%
LEN $45.31 0.00%
RAX $22.87 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs